← Open Payments lookup

ROBERTO SIRVEN: Open Payments

NPI 1902235476 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,900 in 118 payments from 19 companies in 2025. Trend: 2023 $2,355 · 2024 $2,650 · 2025 $2,900

Food & beverage: $2,866Education: $34
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP27$653
GlaxoSmithKline, LLC.15$323
CSL Behring7$245
Galderma Laboratories, L.P.9$243
BioCryst US Sales Co., LLC12$226
Novartis Pharmaceuticals Corporation5$218
Regeneron Healthcare Solutions, Inc.9$189
Amgen Inc.8$172
GENZYME CORPORATION6$151
Optinose US, Inc.5$128

Products named: DUPIXENT, TEZSPIRE, XOLAIR, NEMLUVIO, FASENRA, ORLADEYO, Andembry, NUCALA.

Industry payments across FL — which companies pay providers there.